MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study), a Phase 3 trial to  evaluate the use of Telix’s commercial PSMA-PET^[1] imaging agents, Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) and Gozellix® (kit for the preparation of gallium Ga 68 gozetotide injection) in the initial prostate cancer diagnosis setting. The dose was administered under the supervision of Dr. Brian Mazzarella at Urology Austin and supplied by RLS Radiopharmacies.

BiPASS™ is the first study designed to gain marketing authorization for ⁶⁸Ga-PSMA-PET^[2] imaging in the pre-biopsy setting. The prospective, open-label Phase 3 trial will enroll 250 patients across sites in the U.S. and Australia. The study aims to determine whether combining MRI^[3] with Illuccix/Gozellix ⁶⁸Ga-PSMA-11 PET can improve diagnostic accuracy and reduce unnecessary biopsies compared to current standard practice. Men with elevated PSA^[4] often proceed from an inconclusive MRI to template prostate biopsy. This procedure is stressful and unpleasant, can lead to complications^[5] and frequently proves to be of no benefit to the patient^[6].

In the U.S., more than one million prostate biopsies are performed annually, yet up to 75% are negative^[6], and one in four patients declines the physician recommendation of receiving a biopsy^[7]. The objective of BiPASS™ is to demonstrate improved lesion detection and patient stratification by integrating non-invasive molecular Illuccix/Gozellix ⁶⁸Ga-PSMA-11 PET imaging early in the diagnostic pathway, to enable biopsy de-escalation or, alternatively, greater biopsy precision when administered.

If the BiPASS™ study achieves its primary objectives, it could lead to a reduction in unnecessary biopsies, improved patient experience, and a significant expansion of access to precision imaging for patients with suspected prostate cancer, potentially increasing the use of ⁶⁸Ga-PSMA-11 PET in a large new patient population.

Dr. Mazzarella, Vice President of Research for Urology America, said, “We’re excited to participate in the BiPASS trial at Urology Austin, which brings together promising technologies and emerging trends in patient care.  If BiPASS is successful in meeting its primary endpoint, it could eliminate the need for biopsy—reducing risks, side effects, and costs—and improve decision-making for providers and patients.”

Kevin Richardson, Chief Executive Officer, Telix Precision Medicine, added, “Illuccix and Gozellix are already transforming how clinicians treat and manage prostate cancer. By initiating this trial, we are reinforcing Telix’s commitment to patient centricity, clinical innovation, and industry leadership—with the goal of eliminating invasive biopsy.”

About BiPASS™

BiPASS™ (ClinicalTrials.gov ID: NCT07052214) leverages promising clinical findings from the PRIMARY^[8] and PRIMARY2^[9] studies, which demonstrated that MRI combined with ⁶⁸Ga-PSMA-11 PET can better define or rule out prostate cancer and guide active surveillance before invasive biopsy. Professor Louise Emmett, Principal Investigator for PRIMARY, serves on the BiPASS™ Steering Committee and as an Investigator on the study.

About Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection)

Illuccix, after radiolabeling with ⁶⁸Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive therapy, those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level, and for selection of patients who are indicated for PSMA-directed therapy as described in the prescribing information of the therapeutic products.

About Gozellix® (kit for the preparation of gallium Ga 68 gozetotide injection)

Gozellix, after radiolabeling with ⁶⁸Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive therapy, and those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Illuccix, Telix’s first generation PSMA-PET imaging agent, has been approved in multiple markets globally. Gozellix has been approved by the U.S. FDA^[10]. Illuccix and Gozellix have not received regulatory approval for initial diagnosis of prostate cancer in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Telix Investor Relations (U.S.)  

Annie Kasparian 
Telix Pharmaceuticals Limited 
Director Investor Relations and Corporate Communications 
Email: annie.kasparian@telixpharma.com 

Media Contact

Eliza Schleifstein
917.763.8106 (Mobile)
Eliza@schleifsteinpr.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including the planned NDA resubmission for TLX101-Px and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

LOS ANGELES, Jan. 17, 2026 /PRNewswire/ — From January 6–8, 2026, Arspura, a premium smart home appliance brand focused on healthier kitchen air, presented its latest IQV™ innovations at CES 2026 and hosted a three-day brand program in Las Vegas. Centered on exclusive technology, respiratory wellness, and user experience, the program brought together experts, product leaders, and real customers to spotlight how better cooking environments can start with better indoor air management.

At the heart of Arspura’s CES showcase was its proprietary IQV™ Dynamic Particulate Capture Technology, designed to capture cooking smoke, grease particles, and odor at the source—helping reduce the common “smoke escape” problem many households experience with traditional ventilation. Through live demonstrations and deep-dive sessions, Arspura emphasized a clear brand promise for modern kitchens: Cook freely, breathe freely.

To watch highlights from Arspura’s CES 2026 showcase, visit:

https://www.youtube.com/watch?v=owPq9B5GcLE

Day 1: Uncovering the Kitchen’s Invisible Health Threats

On the first day of CES 2026, Arspura kicked off its brand program with a keynote by Professor Francesca Dominici of the Harvard T.H. Chan School of Public Health (Professor of Biostatistics & Data Science; Professor of Environmental Health).

Drawing on her research on air pollution and health, she highlighted the risks of fine particulate matter (PM2.5) and emphasized that even low-level exposure can make people sick. She noted that PM2.5 can be particularly hazardous for older adults, people with existing health conditions, and individuals with asthma, and stressed that preventing cooking-related PM2.5 from dispersing indoors and reducing exposure at the source is crucial for family health.

Reflecting on this message, Arspura underscored its commitment to helping more households—especially those with asthma or nasal sensitivities—cook with greater comfort by reducing smoke and odor irritation, so more people can truly cook freely and breathe freely.

Day 2: Redefining a New Standard for Smoke-Free Cooking

On the second day, Arspura’s product manager led a technical session explaining how IQV™ airflow design works together with high-airspeed capture (up to 13 m/s) to deliver high capture performance with minimal smoke escape. The presentation framed Arspura’s approach as more than a product: a combination of technology and daily usability designed to make healthy cooking feel effortless.

Arspura also welcomed a special on-site visit and interview from media figure Yang Lan, who explored the booth experience and shared positive feedback on IQV™ technology and the IQV Hood concept—particularly its relevance for people sensitive to cooking fumes who want a more comfortable kitchen environment.

Day 3: Bringing Healthy Kitchen Living Into Everyday Ease

Arspura closed out CES 2026 with strong momentum, earning five awards during the show. To cap the three-day program, the brand invited its first group of IQV Hood users for a face-to-face sharing session, paired with immersive, hands-on demonstrations. Through interactive experiences and practical use scenarios, attendees felt firsthand how the product can deliver “health protection” and “easy cleaning” simultaneously, translating the idea of a healthier kitchen into tangible everyday value.

Passionate home cooks also shared how they had previously tried multiple traditional range hoods yet still struggled with smoke escape and lingering odors, while Arspura’s IQV™ performance provided noticeably improved smoke capture and deodorization—making cooking more enjoyable and inspiring friends and family to upgrade after seeing the results.

What’s Next for Arspura

Backed by strong recognition at CES 2026 and reinforced by firsthand user stories, Arspura’s IQV™ showcase signaled a growing shift toward kitchen ventilation solutions that prioritize both health and everyday usability. Building on this momentum, Arspura will continue to develop smarter, cleaner-air technologies for modern homes.

For more information, visit arspura.com.

In the news release, NYSE Content Advisory: Pre-Market Update + Singapore Software Firm TechCreate Rings NYSE Bell after IPO, issued 16-Jan-2026 by New York Stock Exchange over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows:

NYSE Content Advisory: Pre-Market Update + Singapore Software Firm TechCreate Rings NYSE Bell after IPO

NEW YORK, Jan. 16, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.  

Kristen Scholer delivers the pre-market update on January 16^th

• Equities are higher this morning, lifted by tech enthusiasm, with chipmakers leading gains after Taiwan Semiconductor’s upbeat outlook and news of a U.S.–Taiwan trade deal involving at least $250B in Taiwanese chip and tech investment in U.S. production
• The stock rally is broadening, as the small‑cap Russell 2000 climbs too; experts say more stocks could benefit in the new year thanks to continued economic resilience.
• Tune in to NYSE Live at 9 a.m. ET as Tech‑Create Group celebrates its NYSE American IPO; CEO Heng Hai Lim will join to discuss the company’s real‑time payments, digital banking, and cybersecurity solutions.

Opening Bell
TechCreate Group celebrates its recent IPO

Closing Bell
Legendary New York Knicks Alumni tip-off the franchise’s Alumni Homecoming Weekend

Click here to download the NYSE TV App

Correction: The video has been updated in this version of the release. 

Video – https://mma.prnasia.com/media2/2863581/NYSE_Market_Update_Jan_16.mp4

TAIPEI, Jan. 17, 2026 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, strengthens its strategic partnership with NVIDIA by unveiling a new generation of flagship products built on NVIDIA’s latest platform at CES 2026. The lineup spans new GeForce RTX™ 5090 graphics cards, powerful GeForce RTX™ laptops with built-in NVIDIA Studio, and G-SYNC Compatible gaming monitors, leveraging NVIDIA’s cutting-edge GPU, RTX™ AI, and display technologies. Building on this foundation, GIGABYTE layers its own advanced cooling, system-control, and display innovations to deliver a uniquely powerful and polished experience for both gamers and creators.

Leading the graphics card lineup, the AORUS GeForce RTX™ 5090 INFINITY is powered by the NVIDIA Blackwell architecture, leveraging GeForce RTX™ 50 Series capabilities to power next-level RTX gaming and AI computing. Equipped with a massive level of AI horsepower, the RTX 50 Series enables new experiences and next-level graphics fidelity. Multiply performance with NVIDIA DLSS 4, generate images at unprecedented speed, and unleash creativity with NVIDIA Studio. To support the GPU in performing at its full potential, GIGABYTE reinforces the design with the WINDFORCE HYPERBURST Cooling System, combining a separated PCB design, patented Hawk fans, and an additional Overdrive Fan for extra cooling headroom under heavy loads. The result is more sustained peak performance, wrapped in a premium showcase design featuring a circular heatsink, a die-cast metal backplate, and iconic RGB Halo lighting.

For mobile users, the AORUS MASTER 16 brings GeForce RTX™ performance powered by NVIDIA Blackwell for gaming and creator workloads, backed by NVIDIA Studio and Studio Drivers to ensure stability in leading creative apps. GIGABYTE elevates the experience with WINDFORCE Infinity EX thermal design rated for 230W thermal power to sustain performance in a thin form factor, and GiMATE, GIGABYTE’S exclusive AI agent that consolidates key system settings into clear, mode-based choices and workflow-friendly shortcuts. Together, NVIDIA Studio’s reliability and GIGABYTE’s GiMATE usability help users get RTX™ gaming performance and smoother creative throughput without constantly tuning profiles.

Rounding out the ecosystem, the G-SYNC Compatible GIGABYTE MO34WQC36, MO32U24, and MO27Q28GR gaming monitors validate a baseline VRR experience by matching display refresh rate to GPU frame rate for tear-free, reduced-stutter gameplay. Building on gameplay smoothness delivered by NVIDIA G-SYNC, GIGABYTE adds its exclusive Tactical Features, a suite of built-in tools designed to sharpen precision and control. For example, Tactical Switch 2.0 enables one-click switching between resolutions and aspect ratios such as 4:3 or 5:4, offering greater flexibility for different game types. Additionally, Aim Stabilizer intelligently inserts black frames to reduce motion blur, and Game Assist overlays such as a custom crosshair and timer for additional competitive edge.

By strengthening collaboration with NVIDIA across graphics cards, laptops, and displays, this lineup leverages GIGABYTE’s leadership in cooling, system control, and display tuning to translate platform innovation into real-world advantages for everyday AI gaming and creation. Learn more at: https://bit.ly/GIGABYTE_Event_CES_2026_NV

Ships Worldwide January 16: The Upgraded Tactile Fabric and dynamic support mark the start of a restorative work era.

HONG KONG, Jan. 17, 2026 /PRNewswire/ — Following immense anticipation, LiberNovo, the pioneer of dynamic ergonomic seating, today officially announced the immediate availability of its new Moss Green variant for the LiberNovo Omni chair. The new model, which builds on the success of Midnight Black and Space Grey, is now available globally, with launch promotions for US customers.

This launch responds directly to growing user demand for seating that blends world-class ergonomic engineering with a warm, natural aesthetic. The Moss Green edition is ready for immediate order and marks a key milestone in the company’s 2026 global expansion, allowing users to invest in both their physical support and their home environment.

Engineered for Presence

The Moss Green LiberNovo Omni provides a comprehensive ergonomic solution for today’s intensive creators. It serves programmers and remote workers who demand sustained focus, alongside creatives and gamers who require seamless, adaptive support during rapid task switching, all guided by the principle: Support by Motion, Defined by Comfort.

Color & Comfort Refinement

Inspired by forest moss, the Moss Green hue blends deep green with gentle warmth, creating an understated yet vibrant tone that immediately conveys emotional comfort. This natural aesthetic subtly integrates a sense of nature into any workspace, making the environment more calming and restorative.

In addition to the new color, the Moss Green design debuts a significant material refinement: a short-pile surface that is exceptionally soft and delicate, yet remains breathable and skin-friendly for superior comfort. Crucially, this luxurious feel is matched by industry-leading durability:

• Abrasion resistance: Tested to withstand more than 50,000 wear cycles
• Pilling resistance: Grade 4 after 5,000 cycles
• Color fastness (dry): Grade 4

Ergonomic Intelligence for Every Task

The Moss Green edition retains the LiberNovo Omni’s core dynamic ergonomic system, positioning it as the world’s first chair to respond dynamically to the body’s natural movements. This is critical for users focused on health and or managing body pain.

• Dynamic Support System: Instantly adjusts to posture shifts, maintaining continuous lumbar alignment
• Bionic FlexFit Backrest: Utilizes 16 pivot points and 8 adaptive panels for comprehensive, full-back support
• Four Recline Modes: Ranging from 105° for focused work to 160° for deep spinal decompression with OmniStretch, ideal for recovery during long sessions

Limited-Time Discounts & Bundles

To celebrate the launch, customers can access limited-time discounts across all bundles and configurations, offering savings of up to 32% off MSRP.

North America Exclusive Gift Package: The first 1,000 U.S. orders over $800 and the first 500 Canada orders over CA$1,200 will each receive an exclusive three-piece gift set, including a silk eye mask, an eco tote bag, and a supportive footrest cushion.

Specific North American Availability

Please note the specific timing for the Official Sale period:

• United States (PST/UTC-8):
  • Official Sale begins on January 16th at 18:00 (PST) and runs until March 16th at 18:00 (PST).
• Canada (EST):
  • Official Sale begins on January 17th at 01:00 (EST) and runs until March 17th at 01:00 (EST).

Pricing and How to Order

The LiberNovo Omni Moss Green Basic Bundle starts at $829 USD (MSRP: $1,099), reflecting the special launch discounts. All orders are fulfilled via fast, warehouse-direct shipping.

Begin your restorative work journey and secure your chair today by visiting:

https://libernovo.com/

YIWU, China, Jan. 16, 2026 /PRNewswire/ — Yiwugo.com, the official website of the Yiwu Commodity Market, is the largest commodity wholesale market in the world. On the afternoon of January 16, the award ceremony for the 2025 Yiwugo’s Top 10 Vendors Competition was successfully held at the Expo Center Hotel in Yiwu. Thousands of leading figures from diverse segments of the Yiwu market, together with representatives from industrial belts across the country, gathered to witness this landmark event.

Over the past year, due to their deep engagement with Yiwugo and their exceptional capabilities, Yiwu Gemei Electric Appliance, Xuping Jewelry, Ufree Gangao Warwick, Kemei Electrical Equipment, Zhangweichao Socks Firm, Little Bee Towels, Yiwu Aishang Daily Necessities Factory, Jinhua Siji Lvkang Daily Necessities, Zhejiang Pujiang Pudong No.1 Lock Firm, and Yiwu Hanbang Daily Necessities Firm secured the title of “2025 Yiwugo’s Top 10 Vendors”.

As an annual gala and a vital barometer of the Yiwu market, the Yiwugo’s Top 10 Vendors Competition has been successfully held for 13 consecutive years. Over the past decade, Yiwugo has remained steadfast in its mission to identify and honor benchmark enterprises that spearhead industrial transformation. To date, these efforts have brought to prominence a group of high-quality enterprises distinguished by robust brand strength and an exceptional industry reputation.

In recent years, as Yiwugo’s brand visibility and market influence continue to increase, the Competition has drawn growing attention and active participation from merchants across the Yiwu market as well as industrial belts nationwide.

A review of previous Top 10 Vendors lists shows a mix of seasoned players and rising stars. This year is no exception: veterans such as Yiwu Gemei Electric Appliance, Xuping Jewelry, Kemei Electrical Equipment, Zhangweichao Socks Firm, Yiwu Aishang Daily Necessities Factory, and Yiwu Hanbang Daily Necessities Firm demonstrated sustained excellence, while the performances of newcomers like Ufree Gangao Warwick and Zhejiang Pujiang Pudong No.1 Lock Firm were particularly impressive.

“During this year’s Competition, many customers reached out to me after seeing the rankings to cheer me on.” Operating in District 2 of the Yiwu International Trade City, Ufree Gangao Warwick specializes in hairdressing scissors, high-speed hair dryers, straighteners, curling irons, hot air brushes, and other beauty gadgets. Its products perform strongly across Europe, the US, South America, the Middle East, and Southeast Asia, ranking among the top in their respective categories on cross-border e-commerce platforms such as Amazon.

Founded in 1995, Ufree Gangao Warwick has remained steadfast in its brand-led strategy, with its proprietary brands now registered in more than 100 countries. “We joined Yiwugo the moment it launched. Many customers have discovered our offline store through the platform, which has delivered tangible results in traffic generation, transaction conversion, and brand exposure,” said Lin Yuncun, head of Ufree Gangao Warwick. This year marks the company’s first debut on the Top 10 Vendors list, an achievement widely regarded as an endorsement from both the market and its customers. Ufree Gangao Warwick will cherish this achievement and use the momentum from the competition to further strengthen its brand influence, laying a solid foundation for advancing its global brand agency strategy in the year ahead.

Zhejiang Pujiang Pudong No.1 Lock Firm also made its first appearance on the list this year. A true “dark horse”, the company joined Yiwugo 14 years ago and, after years of steady development, secured an impressive ninth place in its debut ranking.

“We specialize in wire mesh products, including welded wire mesh and fencing systems. Our offerings perform well in regions with strong infrastructure demand, such as Africa and South America. Africa, in particular, has been a core market for us. Through years of focused efforts, our brand has established a solid level of recognition across West African countries,” said Guo Xiaolei, head of Zhejiang Pujiang Pudong No.1 Lock Firm. By taking part in the Top 10 Vendors Competition, the company hopes to leverage the event’s visibility and Yiwugo’s reach to introduce its own brand to a wider overseas audience, expand into new markets, and unlock fresh growth opportunities.

Whether established leaders or first-time entrants, these award-winning vendors not only stand out in sales performance but also set industry benchmarks in branding, digitization, and sustainable development. They embody robust growth momentum, outstanding innovation ability, and extensive market influence, collectively showcasing the resilience and dynamism of the Yiwu market.

Today, the wave of digital trade is rapidly reshaping the industry landscape. Deeply rooted in the market and keenly responsive to its evolution, Yiwugo has consistently positioned innovation and transformation at the heart of its development strategy. Last October, the platform officially launched its in-store live-streaming initiative. Designed to support vendors at various stages of growth, Yiwugo offers multi-channel account setup services—including WeChat Channels, Douyin, and TikTok—enabling vendors to tap into new global trade opportunities.

Going forward, Yiwugo will continue to strengthen innovation, push beyond service boundaries, and expand its business ecosystem. By empowering merchants to fully embrace new digital-trade models, the platform aims to foster faster, closer connections between buyers and sellers. With digital and intelligent technologies, Yiwugo will be able to promote deeper integration of online and offline commerce, accelerate market transformation, and boost industry-wide efficiency.

HONG KONG, Jan. 16, 2026 /PRNewswire/ — On January 13, WebX held its Global Chain Commerce Launch Conference and the ceremony of Chain Capital. The event, themed “Innovating Together, Connecting the World”, brought together more than 1,000 participants. The launch comes as Web3 and AI reshape the global digital economy.

Ho Kwan-yiu, Member of the National Committee of the Chinese People’s Political Consultative Conference (CPPCC) and Member of the Legislative Council of the Hong Kong Special Administrative Region (HKSAR); Zhu Lieyu, Member of the National Committee of the CPPCC and Supervisor of the Supreme People’s Court and over 100 guests attended the conference. Thomas Fok, on behalf of the Fok family, sent a floral tribute. And the Guangdong General Chamber of Commerce sent a congratulatory telegram.

CHAN Pak-lai, Under Secretary for Commerce and Economic Development of the Hong Kong SAR Government, delivered the opening remarks. He said Hong Kong is an ideal partner for mainland enterprises to expand globally and build supply chains. Li Nonghe, President of the World Chinese Business Advancement Association, spoke on the shifting geopolitics and the digital transformation of the real economy.

Zhuang Jiyong, Chairman of the Board of WebX, delivered a welcome address. He said WebX aims to create a closed-loop ecosystem integrating industry, capital and traffic. The company is building a “5-in-1” strategic system based on large-model capabilities to link leading industry and capital clusters.

Zhuang Jiyong joined CHAN Pak-li, Li Nonghe, Wang Xin (Executive Chairman of the Global Cross-Border E-commerce Association), Guo Weide (Chairman of Global United Investment Group), Xiao Qiuli (General Manager of GGBingo), and 26 other leaders to jointly initiate the official launch. Zhuang said WebX positions itself at the intersection of Web3 and AI integration, with a core mission of “connecting the digital economy and empowering real industries.” Zhuang reiterated his strategic focus: “selling products is fundamental.” WebX has developed a dual-engine model of “industry & capital,” combining the synergy of traditional capital and Web3 digital capital.

Wang Xin shared insights on cross-border e-commerce trends, discussing the value of integrating chain-commerce models with cross-border e-commerce amid accelerating global consumer segmentation.

Dong De, President of WebX, presented the development plan for Chain Capital, focusing on technology and industry investment opportunities amid differentiation in global capital markets. Geng Yong, Director of WebX’s Innovative Industry Cluster Division, introduced the platform’s approach to integrating a gaming ecosystem.